Mr. Waissbluth has extensive early stage drug development and commercialization experience. Before joining ScarX Therapeutics, Ivan worked at MaRS Innovation, where he managed the development of multiple nonclinical therapeutic programs ranging from drug discovery, formulation development, and nonclinical proof of concept studies targeting a variety of different indications. Ivan also has experience performing investment diligence while working a

Stephen Whitehead is a senior executive leader in the biopharma / pharma industry with extensive experience at several leading multi-nationals. Stephen was Vice President of Commercial & Strategic Advancement, and a Management Committee Member at Wyeth. He has also held positions of increasing responsibility at American Cyanamid and J&J. Stephen has a strong background in business development, strategic planning, licensing, late-stage commerciali